Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for KALYDECO
- The Multicenter Topic Trial
- Personalized Theratyping Trial
- Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
- Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy
- VX-770 for the Treatment of Chronic Bronchitis
- The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
- A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis
- Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations
- A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis
- A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age and Have an Ivacaftor-Responsive CFTR Mutation
- A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients
- Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
- Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656
- Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)
- Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects
- (Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?
- TOPIC Trial for COPD
- Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation
- CPET in CF Patients With One G551D Mutation Taking VX770
- Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
- Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation
- Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
- Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation
- Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)
Clinical trials list
click for details